Medical Care

Global Autologous CAR-T Cell Therapy Market Research Report 2025

This report aims to provide a comprehensive presentation of the global market for Autologous CAR-T Cell Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Autologous CAR-T Cell Therapy.
The Autologous CAR-T Cell Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Autologous CAR-T Cell Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Autologous CAR-T Cell Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
JW (Cayman) Therapeutics
Gilead (Kite Pharma)
Bristol Myers Squibb
Novartis
Legend Biotech Corporation
Segment by Type
Target: CD19
Target: BCMA
Other
Segment by Application
Hematological Tumors
Solid Tumor
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Autologous CAR-T Cell Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Autologous CAR-T Cell Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Target: CD19
1.2.3 Target: BCMA
1.2.4 Other
1.3 Market by Application
1.3.1 Global Autologous CAR-T Cell Therapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hematological Tumors
1.3.3 Solid Tumor
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Autologous CAR-T Cell Therapy Market Perspective (2020-2031)
2.2 Global Autologous CAR-T Cell Therapy Growth Trends by Region
2.2.1 Global Autologous CAR-T Cell Therapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Autologous CAR-T Cell Therapy Historic Market Size by Region (2020-2025)
2.2.3 Autologous CAR-T Cell Therapy Forecasted Market Size by Region (2026-2031)
2.3 Autologous CAR-T Cell Therapy Market Dynamics
2.3.1 Autologous CAR-T Cell Therapy Industry Trends
2.3.2 Autologous CAR-T Cell Therapy Market Drivers
2.3.3 Autologous CAR-T Cell Therapy Market Challenges
2.3.4 Autologous CAR-T Cell Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Autologous CAR-T Cell Therapy Players by Revenue
3.1.1 Global Top Autologous CAR-T Cell Therapy Players by Revenue (2020-2025)
3.1.2 Global Autologous CAR-T Cell Therapy Revenue Market Share by Players (2020-2025)
3.2 Global Autologous CAR-T Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Autologous CAR-T Cell Therapy Revenue
3.4 Global Autologous CAR-T Cell Therapy Market Concentration Ratio
3.4.1 Global Autologous CAR-T Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Autologous CAR-T Cell Therapy Revenue in 2024
3.5 Global Key Players of Autologous CAR-T Cell Therapy Head office and Area Served
3.6 Global Key Players of Autologous CAR-T Cell Therapy, Product and Application
3.7 Global Key Players of Autologous CAR-T Cell Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Autologous CAR-T Cell Therapy Breakdown Data by Type
4.1 Global Autologous CAR-T Cell Therapy Historic Market Size by Type (2020-2025)
4.2 Global Autologous CAR-T Cell Therapy Forecasted Market Size by Type (2026-2031)
5 Autologous CAR-T Cell Therapy Breakdown Data by Application
5.1 Global Autologous CAR-T Cell Therapy Historic Market Size by Application (2020-2025)
5.2 Global Autologous CAR-T Cell Therapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Autologous CAR-T Cell Therapy Market Size (2020-2031)
6.2 North America Autologous CAR-T Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Autologous CAR-T Cell Therapy Market Size by Country (2020-2025)
6.4 North America Autologous CAR-T Cell Therapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Autologous CAR-T Cell Therapy Market Size (2020-2031)
7.2 Europe Autologous CAR-T Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Autologous CAR-T Cell Therapy Market Size by Country (2020-2025)
7.4 Europe Autologous CAR-T Cell Therapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Autologous CAR-T Cell Therapy Market Size (2020-2031)
8.2 Asia-Pacific Autologous CAR-T Cell Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Autologous CAR-T Cell Therapy Market Size by Region (2020-2025)
8.4 Asia-Pacific Autologous CAR-T Cell Therapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Autologous CAR-T Cell Therapy Market Size (2020-2031)
9.2 Latin America Autologous CAR-T Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Autologous CAR-T Cell Therapy Market Size by Country (2020-2025)
9.4 Latin America Autologous CAR-T Cell Therapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Autologous CAR-T Cell Therapy Market Size (2020-2031)
10.2 Middle East & Africa Autologous CAR-T Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Autologous CAR-T Cell Therapy Market Size by Country (2020-2025)
10.4 Middle East & Africa Autologous CAR-T Cell Therapy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 JW (Cayman) Therapeutics
11.1.1 JW (Cayman) Therapeutics Company Details
11.1.2 JW (Cayman) Therapeutics Business Overview
11.1.3 JW (Cayman) Therapeutics Autologous CAR-T Cell Therapy Introduction
11.1.4 JW (Cayman) Therapeutics Revenue in Autologous CAR-T Cell Therapy Business (2020-2025)
11.1.5 JW (Cayman) Therapeutics Recent Development
11.2 Gilead (Kite Pharma)
11.2.1 Gilead (Kite Pharma) Company Details
11.2.2 Gilead (Kite Pharma) Business Overview
11.2.3 Gilead (Kite Pharma) Autologous CAR-T Cell Therapy Introduction
11.2.4 Gilead (Kite Pharma) Revenue in Autologous CAR-T Cell Therapy Business (2020-2025)
11.2.5 Gilead (Kite Pharma) Recent Development
11.3 Bristol Myers Squibb
11.3.1 Bristol Myers Squibb Company Details
11.3.2 Bristol Myers Squibb Business Overview
11.3.3 Bristol Myers Squibb Autologous CAR-T Cell Therapy Introduction
11.3.4 Bristol Myers Squibb Revenue in Autologous CAR-T Cell Therapy Business (2020-2025)
11.3.5 Bristol Myers Squibb Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Autologous CAR-T Cell Therapy Introduction
11.4.4 Novartis Revenue in Autologous CAR-T Cell Therapy Business (2020-2025)
11.4.5 Novartis Recent Development
11.5 Legend Biotech Corporation
11.5.1 Legend Biotech Corporation Company Details
11.5.2 Legend Biotech Corporation Business Overview
11.5.3 Legend Biotech Corporation Autologous CAR-T Cell Therapy Introduction
11.5.4 Legend Biotech Corporation Revenue in Autologous CAR-T Cell Therapy Business (2020-2025)
11.5.5 Legend Biotech Corporation Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Autologous CAR-T Cell Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Target: CD19
Table 3. Key Players of Target: BCMA
Table 4. Key Players of Other
Table 5. Global Autologous CAR-T Cell Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Autologous CAR-T Cell Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Autologous CAR-T Cell Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Autologous CAR-T Cell Therapy Market Share by Region (2020-2025)
Table 9. Global Autologous CAR-T Cell Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Autologous CAR-T Cell Therapy Market Share by Region (2026-2031)
Table 11. Autologous CAR-T Cell Therapy Market Trends
Table 12. Autologous CAR-T Cell Therapy Market Drivers
Table 13. Autologous CAR-T Cell Therapy Market Challenges
Table 14. Autologous CAR-T Cell Therapy Market Restraints
Table 15. Global Autologous CAR-T Cell Therapy Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Autologous CAR-T Cell Therapy Market Share by Players (2020-2025)
Table 17. Global Top Autologous CAR-T Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Autologous CAR-T Cell Therapy as of 2024)
Table 18. Ranking of Global Top Autologous CAR-T Cell Therapy Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Autologous CAR-T Cell Therapy Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Autologous CAR-T Cell Therapy, Headquarters and Area Served
Table 21. Global Key Players of Autologous CAR-T Cell Therapy, Product and Application
Table 22. Global Key Players of Autologous CAR-T Cell Therapy, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Autologous CAR-T Cell Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Autologous CAR-T Cell Therapy Revenue Market Share by Type (2020-2025)
Table 26. Global Autologous CAR-T Cell Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Autologous CAR-T Cell Therapy Revenue Market Share by Type (2026-2031)
Table 28. Global Autologous CAR-T Cell Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Autologous CAR-T Cell Therapy Revenue Market Share by Application (2020-2025)
Table 30. Global Autologous CAR-T Cell Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Autologous CAR-T Cell Therapy Revenue Market Share by Application (2026-2031)
Table 32. North America Autologous CAR-T Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Autologous CAR-T Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Autologous CAR-T Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Autologous CAR-T Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Autologous CAR-T Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Autologous CAR-T Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Autologous CAR-T Cell Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Autologous CAR-T Cell Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Autologous CAR-T Cell Therapy Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Autologous CAR-T Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Autologous CAR-T Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Autologous CAR-T Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Autologous CAR-T Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Autologous CAR-T Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Autologous CAR-T Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 47. JW (Cayman) Therapeutics Company Details
Table 48. JW (Cayman) Therapeutics Business Overview
Table 49. JW (Cayman) Therapeutics Autologous CAR-T Cell Therapy Product
Table 50. JW (Cayman) Therapeutics Revenue in Autologous CAR-T Cell Therapy Business (2020-2025) & (US$ Million)
Table 51. JW (Cayman) Therapeutics Recent Development
Table 52. Gilead (Kite Pharma) Company Details
Table 53. Gilead (Kite Pharma) Business Overview
Table 54. Gilead (Kite Pharma) Autologous CAR-T Cell Therapy Product
Table 55. Gilead (Kite Pharma) Revenue in Autologous CAR-T Cell Therapy Business (2020-2025) & (US$ Million)
Table 56. Gilead (Kite Pharma) Recent Development
Table 57. Bristol Myers Squibb Company Details
Table 58. Bristol Myers Squibb Business Overview
Table 59. Bristol Myers Squibb Autologous CAR-T Cell Therapy Product
Table 60. Bristol Myers Squibb Revenue in Autologous CAR-T Cell Therapy Business (2020-2025) & (US$ Million)
Table 61. Bristol Myers Squibb Recent Development
Table 62. Novartis Company Details
Table 63. Novartis Business Overview
Table 64. Novartis Autologous CAR-T Cell Therapy Product
Table 65. Novartis Revenue in Autologous CAR-T Cell Therapy Business (2020-2025) & (US$ Million)
Table 66. Novartis Recent Development
Table 67. Legend Biotech Corporation Company Details
Table 68. Legend Biotech Corporation Business Overview
Table 69. Legend Biotech Corporation Autologous CAR-T Cell Therapy Product
Table 70. Legend Biotech Corporation Revenue in Autologous CAR-T Cell Therapy Business (2020-2025) & (US$ Million)
Table 71. Legend Biotech Corporation Recent Development
Table 72. Research Programs/Design for This Report
Table 73. Key Data Information from Secondary Sources
Table 74. Key Data Information from Primary Sources
Table 75. Authors List of This Report


List of Figures
Figure 1. Autologous CAR-T Cell Therapy Picture
Figure 2. Global Autologous CAR-T Cell Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Autologous CAR-T Cell Therapy Market Share by Type: 2024 VS 2031
Figure 4. Target: CD19 Features
Figure 5. Target: BCMA Features
Figure 6. Other Features
Figure 7. Global Autologous CAR-T Cell Therapy Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Autologous CAR-T Cell Therapy Market Share by Application: 2024 VS 2031
Figure 9. Hematological Tumors Case Studies
Figure 10. Solid Tumor Case Studies
Figure 11. Autologous CAR-T Cell Therapy Report Years Considered
Figure 12. Global Autologous CAR-T Cell Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Autologous CAR-T Cell Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Autologous CAR-T Cell Therapy Market Share by Region: 2024 VS 2031
Figure 15. Global Autologous CAR-T Cell Therapy Market Share by Players in 2024
Figure 16. Global Top Autologous CAR-T Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Autologous CAR-T Cell Therapy as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Autologous CAR-T Cell Therapy Revenue in 2024
Figure 18. North America Autologous CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Autologous CAR-T Cell Therapy Market Share by Country (2020-2031)
Figure 20. United States Autologous CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Autologous CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Autologous CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Autologous CAR-T Cell Therapy Market Share by Country (2020-2031)
Figure 24. Germany Autologous CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Autologous CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Autologous CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Autologous CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Autologous CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Autologous CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Autologous CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Autologous CAR-T Cell Therapy Market Share by Region (2020-2031)
Figure 32. China Autologous CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Autologous CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Autologous CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Autologous CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Autologous CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Autologous CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Autologous CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Autologous CAR-T Cell Therapy Market Share by Country (2020-2031)
Figure 40. Mexico Autologous CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Autologous CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Autologous CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Autologous CAR-T Cell Therapy Market Share by Country (2020-2031)
Figure 44. Turkey Autologous CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Autologous CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Autologous CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. JW (Cayman) Therapeutics Revenue Growth Rate in Autologous CAR-T Cell Therapy Business (2020-2025)
Figure 48. Gilead (Kite Pharma) Revenue Growth Rate in Autologous CAR-T Cell Therapy Business (2020-2025)
Figure 49. Bristol Myers Squibb Revenue Growth Rate in Autologous CAR-T Cell Therapy Business (2020-2025)
Figure 50. Novartis Revenue Growth Rate in Autologous CAR-T Cell Therapy Business (2020-2025)
Figure 51. Legend Biotech Corporation Revenue Growth Rate in Autologous CAR-T Cell Therapy Business (2020-2025)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies